ES2180200T3 - Composicion para la supresion de los sintomas de abstinencia y ansia de alcohol en alcoholicos y prevencion del abuso de alcohol en individuos sanos. - Google Patents

Composicion para la supresion de los sintomas de abstinencia y ansia de alcohol en alcoholicos y prevencion del abuso de alcohol en individuos sanos.

Info

Publication number
ES2180200T3
ES2180200T3 ES98946703T ES98946703T ES2180200T3 ES 2180200 T3 ES2180200 T3 ES 2180200T3 ES 98946703 T ES98946703 T ES 98946703T ES 98946703 T ES98946703 T ES 98946703T ES 2180200 T3 ES2180200 T3 ES 2180200T3
Authority
ES
Spain
Prior art keywords
alcohol
composition
ansia
alcoholics
abstinence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98946703T
Other languages
English (en)
Spanish (es)
Inventor
Aldo Fassi
Claudio Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of ES2180200T3 publication Critical patent/ES2180200T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Addiction (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ES98946703T 1997-10-03 1998-09-18 Composicion para la supresion de los sintomas de abstinencia y ansia de alcohol en alcoholicos y prevencion del abuso de alcohol en individuos sanos. Expired - Lifetime ES2180200T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000594A IT1295408B1 (it) 1997-10-03 1997-10-03 Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo

Publications (1)

Publication Number Publication Date
ES2180200T3 true ES2180200T3 (es) 2003-02-01

Family

ID=11405277

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98946703T Expired - Lifetime ES2180200T3 (es) 1997-10-03 1998-09-18 Composicion para la supresion de los sintomas de abstinencia y ansia de alcohol en alcoholicos y prevencion del abuso de alcohol en individuos sanos.

Country Status (27)

Country Link
US (1) US6255346B1 (enExample)
EP (1) EP1022960B1 (enExample)
JP (1) JP2001518484A (enExample)
KR (2) KR100530368B1 (enExample)
CN (1) CN1092939C (enExample)
AT (1) ATE220860T1 (enExample)
AU (1) AU730740B2 (enExample)
BG (1) BG64363B1 (enExample)
BR (1) BR9812604A (enExample)
CA (1) CA2305598C (enExample)
CZ (1) CZ291801B6 (enExample)
DE (1) DE69806788T2 (enExample)
DK (1) DK1022960T3 (enExample)
EA (1) EA002177B1 (enExample)
EE (1) EE04036B1 (enExample)
ES (1) ES2180200T3 (enExample)
HU (1) HUP0004336A3 (enExample)
IS (1) IS2234B (enExample)
IT (1) IT1295408B1 (enExample)
MX (1) MXPA00003232A (enExample)
NO (1) NO20001688L (enExample)
NZ (1) NZ503663A (enExample)
PL (1) PL189663B1 (enExample)
PT (1) PT1022960E (enExample)
SK (1) SK283384B6 (enExample)
UA (1) UA66807C2 (enExample)
WO (1) WO1999017623A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
ITRM20020194A1 (it) * 2002-04-09 2003-10-09 Sigma Tau Healthscience Spa Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.
US7776913B2 (en) 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
RU2300376C2 (ru) * 2005-05-11 2007-06-10 МУЗ Городская клиническая больница №3 им. М.А. Подгорбунского г.Кемерово Способ лечения при алкогольном делирии
CN101766672B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766715B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766717B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766716B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766635B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766637B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN106176756A (zh) * 2015-04-30 2016-12-07 刘力 包含手性异构化合物的赖氨酸五维药物组合物及其用途
US20230149338A1 (en) * 2020-04-14 2023-05-18 The Regents Of The University Of California Diagnosis and treatment of addiction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245869B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
DE19527281A1 (de) * 1995-07-26 1997-01-30 Hans Guenter Berner Gmbh Nahrungsergänzungsmittel
EP0776604B1 (en) * 1995-12-01 2002-01-23 Unilever N.V. Microwavable crispy bread-rolls
DK0793962T3 (da) * 1996-03-04 2000-05-22 Sigma Tau Ind Farmaceuti Lægemiddel indeholdende et carnitinderivat til behandling af arteriosclerosis obliterans

Also Published As

Publication number Publication date
EE200000235A (et) 2001-06-15
EP1022960A1 (en) 2000-08-02
WO1999017623A1 (en) 1999-04-15
IS5416A (is) 2000-03-24
EA002177B1 (ru) 2002-02-28
EP1022960B1 (en) 2002-07-24
CZ20001207A3 (cs) 2000-11-15
KR100560097B1 (ko) 2006-03-13
NO20001688L (no) 2000-06-02
EA200000377A1 (ru) 2000-10-30
HUP0004336A2 (hu) 2001-05-28
NO20001688D0 (no) 2000-03-31
NZ503663A (en) 2001-11-30
CA2305598A1 (en) 1999-04-15
HUP0004336A3 (en) 2001-07-30
US6255346B1 (en) 2001-07-03
PL339621A1 (en) 2001-01-02
CA2305598C (en) 2007-11-20
EE04036B1 (et) 2003-06-16
BR9812604A (pt) 2000-08-01
ATE220860T1 (de) 2002-08-15
DE69806788D1 (de) 2002-08-29
MXPA00003232A (es) 2004-03-10
DK1022960T3 (da) 2002-11-04
DE69806788T2 (de) 2003-04-03
PT1022960E (pt) 2002-12-31
CZ291801B6 (cs) 2003-05-14
BG64363B1 (bg) 2004-12-30
KR100530368B1 (ko) 2005-11-22
IT1295408B1 (it) 1999-05-12
CN1092939C (zh) 2002-10-23
JP2001518484A (ja) 2001-10-16
SK4762000A3 (en) 2000-10-09
KR20010030928A (ko) 2001-04-16
AU730740B2 (en) 2001-03-15
AU9366098A (en) 1999-04-27
HK1028714A1 (en) 2001-03-02
CN1276704A (zh) 2000-12-13
PL189663B1 (pl) 2005-09-30
UA66807C2 (uk) 2004-06-15
KR20050088499A (ko) 2005-09-06
BG104286A (en) 2000-11-30
IS2234B (is) 2007-04-15
SK283384B6 (sk) 2003-06-03
ITRM970594A1 (it) 1999-04-03

Similar Documents

Publication Publication Date Title
ES2180200T3 (es) Composicion para la supresion de los sintomas de abstinencia y ansia de alcohol en alcoholicos y prevencion del abuso de alcohol en individuos sanos.
ES2086644T3 (es) Preparado anovulatorio para la contracepcion hormonal.
ES2157307T3 (es) Composicion topica que contiene un antagonista de sustancia p.
AR064896A2 (es) Composicion farmaceutica no higroscopica
ES2094823T3 (es) Pasta dentifrica antimicrobiana.
ES2135370T1 (es) Uso de un extracto de hojas de olea europea como antirradical.
BR0213181A (pt) Combinações de inibidor de cox-2
ES2143705T3 (es) Preparaciones cosmeticas y/o farmaceuticas que contienen tensioactivos sacaricos y gliceridos parciales de acidos grasos.
BRPI9907025B8 (pt) polissacarídeos sintéticos e uso dos mesmos
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.
CA2122431A1 (en) Topical administration of vitamin d to mammals and compositions therefor
ES2086274T3 (es) Preparaciones de especies de crataegus, composiciones farmaceuticas y su uso para prevenir la muerte subita debida a ataque cardiaco y las lesiones cardiovasculares provocadas por reperfusion.
CO4930269A1 (es) Composiciones farmaceuticas
AU2992492A (en) The use of d-fenfluramine and fenfluramine compounds in the treatment of hypertension in insulin-resistant subjects
KR960003728A (ko) 포유류의 허파 모세관 누출을 감소시키는 방법
KR910016327A (ko) 호중구에 의한 엘라스타제 방출 저해제로서의 테니댑의 용도
AR007059A1 (es) Uso de interferon en la preparacion de medicamentos y composiciones via oromucosal o por contacto
NO974956L (no) Terapeutisk sammensetning for artritis
ES2187445T3 (es) Procedimiento para la reduccion de la incidencia de ascitis en avicultura con la ayuda de natamicina.
RU96102365A (ru) Гель для ног
RU95118869A (ru) Состав желатиновых масс для получения капсул
RU96102240A (ru) Ранозаживляющий и противовоспалительный бальзам
AR033424A1 (es) Composiciones farmaceuticas
FR2724845B1 (fr) Compositions de muramyl peptides capables d'inhiber jusqu'a 100% la replication d'un virus de l'immuno-deficience acquise, tel que le vih
RU94018027A (ru) Крем интимного назначения для мужчин